Pediatric IBD Patients Treated With Infliximab and Proactive Drug Monitoring Benefit From Early Concomitant Immunomodulatory Therapy: A Retrospective Analysis of a 10-Year Real-Life Cohort - Concepedia

Concepedia

Publication | Open Access

Pediatric IBD Patients Treated With Infliximab and Proactive Drug Monitoring Benefit From Early Concomitant Immunomodulatory Therapy: A Retrospective Analysis of a 10-Year Real-Life Cohort

DOI Full Paper Access

10

Citations

30

References

2023

Year

Hannes Hoelz, Lena Bragagna, Anna Litwin, Sibylle Koletzko, Thu Giang Le Thi, Tobias Schwerd

Inflammatory Bowel Diseases

Abstract

Early IMM combo-therapy in proactively monitored patients with pIBD significantly prolonged the median LOR free interval compared with late/short or no IMM treatment.

References

	Year	Citations

Page 1